The NCI Community Oncology Research Program (NCORP) is a national network of cancer care investigators, providers, academia, and other organizations that care for diverse populations in health systems.
View the list of publications from NCORP.
The DCP Community Oncology and Prevention Trials Research Group administers this program.
Visit the NCORP website
The program brings cancer clinical trials and control and delivery studies to individuals in their own communities, thereby generating a broadly applicable evidence base that contributes to improved patient outcomes and a reduction in cancer disparities.
NCORP 2020 Virtual Annual Meeting for Grantees
Part 1, August 31, 12 p.m. – 6 p.m. ET; Part 2, October 6, 2 p.m. – 5 p.m. ET. For registration information, visit https://ncorp.cancer.gov/.
Researchers Search the Genome for Clues to Early Age Onset Cancers in Racial/Ethnic Minorities
While researchers have identified some of the genetic changes that lead to cancer development, a key knowledge gap remains: finding the genetic changes that drive the development of cancers that arise at an earlier age than average (early onset) in racially and ethnically diverse populations.
NCI Community Oncology Research Program (NCORP) Expands to More States
The National Cancer Institute (NCI) has awarded 53 grants to researchers in the NCI Community Oncology Research Program (NCORP) to conduct multi-site cancer clinical trials and cancer care delivery studies in their communities.
NCORP Annual Meeting Focuses on Clinical Trials, COVID-19 and Telemedicine
The impact of the COVID-19 pandemic on cancer research and clinical trials, and the growing use of telemedicine garnered much of the focus during Part 1 of the annual meeting of the NCI Community Oncology Research Program (NCORP) on Aug. 31. Part 2 scheduled for October 6, will focus on progress and practices in cancer care delivery research.
NCORP Tissue Procurement Protocol to Open at 12 Community Sites
NCI Cancer Moonshot℠ Biobank Launches Exclusively through 20 NCORP Sites
NCI has launched the Cancer Moonshot℠ Biobank to procure and distribute longitudinal patient biospecimens for cancer research exclusively through 20 community research sites in the NCI Community Oncology Research Program (NCORP).